ESC Premium Access

Modeling the Individual Risk of Thrombosis in Oncology (MIRTO).

Congress Presentation

About the speaker

Doctor Jose Manuel Soria Fernandez

Sant Pau (Spain)
1 presentation
0 follower

4 more presentations in this session

The importance of type of antithrombotic treatment after aortic valve replacement for the risk of future thromboembolic and bleeding events in aortic stenosis - Comparison of mechanical -, bio prosthetic and trans-catheter (TAVI) aortic valve replacement.

Speaker: Associate Professor C. Christersson (Uppsala, SE)


Dual approach cardiac MRI for molecular assessment and interventional treatment of vulnerable coronary plaques in a porcine model.

Speaker: Doctor T. Heidt (Freiburg, DE)


Systemic versus site targeted treatment of neoatherosclerosis.

Speaker: Doctor M. Joner (Munich, DE)


Identification of mirRNA profiles associated with venous thromboembolism and recurrent events (IMPROVEMENTS).

Speaker: Doctor D. Tregouet (Paris, FR)


Access the full session

ESC Grants for Medical Research Innovation

Speakers: Doctor J. Soria Fernandez, Associate Professor C. Christersson, Doctor T. Heidt, Doctor M. Joner, Doctor D. Tregouet

About the event


ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb